Medial Artery Calcification in Peripheral Artery Disease

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2023 Feb 13

PMID 36776265

Authors

Tanner I Kim

Raul J Guzman

Affiliations

Soon will be listed here.

Abstract

Medial artery calcification (MAC) is a distinct, highly regulated process that is often identified in small and mid-sized arteries of the lower extremities. It is associated with advanced age, diabetes, and chronic kidney disease. MAC often occurs in conjunction with atherosclerotic occlusive disease in lower extremity arteries, and when seen together or in isolation, long-term limb outcomes are negatively affected. In patients with peripheral artery disease (PAD), the extent of MAC independently correlates with major amputation and mortality rates, and it predicts poor outcomes after endovascular interventions. It is associated with increased arterial stiffness and decreased pedal perfusion. New endovascular methods aimed at treating calcified lower-extremity lesions may improve our ability to treat patients with limb-threatening ischemia. Although recent developments have increased our understanding of the mechanisms contributing to MAC, further investigations are needed to understand the role of medial calcification in PAD, and to develop strategies aimed at improving patient outcomes.

Citing Articles

Evaluation of sex-based differences in below-the-knee plaque histology in patients who underwent amputation for chronic limb-threatening ischemia.

Kansul F, Vela D, Csore J, Benfor B, Suarez S, Dua A JVS Vasc Sci. 2025; 6:100269.

PMID: 39896044 PMC: 11787704. DOI: 10.1016/j.jvssci.2024.100269.

Systematic review and meta-analysis assessing the status of carotid intima-media thickness and lipid profiles in type 2 diabetes mellitus.

Mashaba R, Phoswa W, Maimela E, Lebelo S, Modjadji P, Mokgalaboni K BMJ Open. 2024; 14(11):e087496.

PMID: 39521468 PMC: 11552583. DOI: 10.1136/bmjopen-2024-087496.

Cardiovascular Effectiveness and Safety of Antidiabetic Drugs in Patients with Type 2 Diabetes and Peripheral Artery Disease: Systematic Review.

Cimellaro A, Cavallo M, Mungo M, Suraci E, Spagnolo F, Addesi D Medicina (Kaunas). 2024; 60(9).

PMID: 39336583 PMC: 11434261. DOI: 10.3390/medicina60091542.

Bioresorbable Scaffolds for Below-the-Knee Arterial Disease: A Literature Review of New Developments.

Cui H, Wu Y Rev Cardiovasc Med. 2024; 25(4):133.

PMID: 39076564 PMC: 11264025. DOI: 10.31083/j.rcm2504133.

Associations of phosphorus concentrations with medial arterial calcification in lower-extremity arteries and diabetic foot in people with diabetes: a retrospective cross-sectional study.

Li P, Li Q, Tang M, Hu X, Tian J, Zhang J Cardiovasc Diabetol. 2024; 23(1):275.

PMID: 39061014 PMC: 11282733. DOI: 10.1186/s12933-024-02361-5.

References

Zettervall S, Soden P, Ultee K, Seldon C, Oh J, McGann K . Elevated serum phosphate levels are associated with decreased amputation-free survival after interventions for critical limb ischemia. J Vasc Surg. 2016; 65(2):431-437. PMC: 5272835. DOI: 10.1016/j.jvs.2016.06.097. View

Lomashvili K, Wang X, Wallin R, ONeill W . Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem. 2011; 286(33):28715-28722. PMC: 3190679. DOI: 10.1074/jbc.M111.251462. View

Paccou J, Brazier M, Mentaverri R, Kamel S, Fardellone P, Massy Z . Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets. Atherosclerosis. 2012; 224(2):283-90. DOI: 10.1016/j.atherosclerosis.2012.04.008. View

Kranenburg G, de Jong P, Mali W, Attrach M, Visseren F, Spiering W . Prevalence and severity of arterial calcifications in pseudoxanthoma elasticum (PXE) compared to hospital controls. Novel insights into the vascular phenotype of PXE. Atherosclerosis. 2016; 256:7-14. DOI: 10.1016/j.atherosclerosis.2016.11.012. View

Chistiakov D, Sobenin I, Orekhov A, Bobryshev Y . Mechanisms of medial arterial calcification in diabetes. Curr Pharm Des. 2014; 20(37):5870-83. DOI: 10.2174/1381612820666140212210451. View

St Hilaire C, Ziegler S, Markello T, Brusco A, Groden C, Gill F . NT5E mutations and arterial calcifications. N Engl J Med. 2011; 364(5):432-42. PMC: 3049958. DOI: 10.1056/NEJMoa0912923. View

Guzman R . Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg. 2007; 45 Suppl A:A57-63. PMC: 2435088. DOI: 10.1016/j.jvs.2007.02.049. View

Chen N, Hsu C, Chen C . The Strategy to Prevent and Regress the Vascular Calcification in Dialysis Patients. Biomed Res Int. 2017; 2017:9035193. PMC: 5329685. DOI: 10.1155/2017/9035193. View

Karamched S, Nosoudi N, Moreland H, Chowdhury A, Vyavahare N . Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease. Sci Rep. 2019; 9(1):2629. PMC: 6385348. DOI: 10.1038/s41598-019-39639-8. View

10.

London G . Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial. 2003; 16(2):85-94. DOI: 10.1046/j.1525-139x.2003.16023.x. View

11.

Segers P, ORourke M, Parker K, Westerhof N, Hughes A . Towards a consensus on the understanding and analysis of the pulse waveform: Results from the 2016 Workshop on Arterial Hemodynamics: Past, present and future. Artery Res. 2017; 18:75-80. PMC: 5470638. DOI: 10.1016/j.artres.2017.03.004. View

12.

Kouis P, Kousios A, Kanari A, Kleopa D, Papatheodorou S, Panayiotou A . Association of non-invasive measures of subclinical atherosclerosis and arterial stiffness with mortality and major cardiovascular events in chronic kidney disease: systematic review and meta-analysis of cohort studies. Clin Kidney J. 2021; 13(5):842-854. PMC: 7849940. DOI: 10.1093/ckj/sfz095. View

13.

Skolnik J, Weiss R, Meyr A, Dhanisetty R, Choi E, Cunningham-Hill M . Evaluating the Impact of Medial Arterial Calcification on Outcomes of Infrageniculate Endovascular Interventions for Treatment of Diabetic Foot Ulcers. Vasc Endovascular Surg. 2021; 55(4):382-388. DOI: 10.1177/1538574421993314. View

14.

Steitz S, Speer M, Curinga G, Yang H, Haynes P, Aebersold R . Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001; 89(12):1147-54. DOI: 10.1161/hh2401.101070. View

15.

van Zuydam N, Stiby A, Abdalla M, Austin E, Dahlstrom E, McLachlan S . Genome-Wide Association Study of Peripheral Artery Disease. Circ Genom Precis Med. 2021; 14(5):e002862. PMC: 8542067. DOI: 10.1161/CIRCGEN.119.002862. View

16.

Jono S, McKee M, Murry C, Shioi A, Nishizawa Y, Mori K . Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87(7):E10-7. DOI: 10.1161/01.res.87.7.e10. View

17.

Kang I, Lee W, Choi B, Choi D, Hong M, Jang Y . Semiquantitative assessment of tibial artery calcification by computed tomography angiography and its ability to predict infrapopliteal angioplasty outcomes. J Vasc Surg. 2016; 64(5):1335-1343. DOI: 10.1016/j.jvs.2016.04.047. View

18.

Menini S, Iacobini C, Ricci C, Blasetti Fantauzzi C, Salvi L, Pesce C . The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Cardiovasc Res. 2013; 100(3):472-80. DOI: 10.1093/cvr/cvt206. View

19.

Alappan H, Kaur G, Manzoor S, Navarrete J, ONeill W . Warfarin Accelerates Medial Arterial Calcification in Humans. Arterioscler Thromb Vasc Biol. 2020; 40(5):1413-1419. DOI: 10.1161/ATVBAHA.119.313879. View

20.

Kamenskiy A, Poulson W, Sim S, Reilly A, Luo J, MacTaggart J . Prevalence of Calcification in Human Femoropopliteal Arteries and its Association with Demographics, Risk Factors, and Arterial Stiffness. Arterioscler Thromb Vasc Biol. 2018; 38(4):e48-e57. PMC: 5864530. DOI: 10.1161/ATVBAHA.117.310490. View